(CYCC)

Payout Frequency

Dividend History

Pay DateAmountEx-DateRecord Date
May 1, 2025$0.152025-04-292025-04-29

Dividends Summary

Company News

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB
GlobeNewswire Inc. • Cyclacel Pharmaceuticals • August 4, 2025

Cyclacel Pharmaceuticals reported preclinical study findings demonstrating that biliary tract cancer cells are sensitive to plogosertib, a PLK1 inhibitor, with potential for targeted cancer treatment using BUBR1 as a biomarker.

Cyclacel Pharmaceuticals May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Benzinga • Zacks • September 3, 2024

Cyclacel Pharmaceuticals (CYCC) has seen a downtrend recently, but a hammer chart pattern and strong agreement among analysts on earnings estimates suggest a potential trend reversal. The article recommends buying the stock now.

All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy
Zacks Investment Research • Zacks Equity Research • June 6, 2024

Cyclacel Pharmaceuticals (CYCC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Penny Stocks To Buy Now? 4 Biotech Stocks To Watch This Week
PennyStocks • J. Samuel • August 18, 2022

Hot biotech penny stocks to watch thanks to MNMD stock today. The post Penny Stocks To Buy Now? 4 Biotech Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.